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      Listeria monocytogenes is a major intracellular bacterial foodborne pathogen capable of causing listeriosis, a severe invasive 
disease.  The elderly,  immunocompromised,  pregnant  women and neonates  are  risk  groups  for  listeriosis  [1].  In  developed 
countries, the globalization of the food industry and the increased consumption of ready-to-eat, particularly chilled foods, has 
increased listeriosis outbreaks in the last 30 years [2]. Listeriosis was the most frequent cause of death due to the consumption of 
contaminated food in Europe (2008-2011) [3], and the third foodborne infection concerning illness cost and quality life losses in 
the USA [4]; mortality is one of the highest among bacterial infections (> 30%) [3]. Although an active surveillance program for 
listeriosis doesn’t exist in Portugal, our research group demonstrated that listeriosis occurs at levels similar to those encountered 
in other countries [5, 6]. 	

      Although 13 serotypes have been identified in L. monocytogenes, 95% of the strains isolated from foods and human clinical 
cases belong to serotypes 1/2a, 1/2b, 1/2c, and 4b [7]. Strains of L. monocytogenes can be also distinguished into four genetic 
lineages (I to IV). The majority of human listeriosis outbreaks have been linked to lineage I serotype 4b isolates, even though 
some outbreaks have been caused by lineage I serotype 1/2b and lineage II serotype 1/2a isolates [8].  The majority of studies 
involving clinical isolates characterization have been performed by France and USA research groups, and point out that lineage I 
isolates are overrepresented among isolates from human listeriosis cases (predominantly serotype 4b), while lineage II isolates 
appear to be overrepresented among food isolates [9]. As overrepresentation of lineage I strains among human listeriosis cases 
cannot be attributed to more frequent exposure to these strains it has been hypothesized that lineage I isolates have a higher 
pathogenicity in comparison to isolates of lineage II. 	

      Mutations leading to a PMSC in inlA  are responsible for attenuated mammalian virulence. In this study, as previously 
observed by other authors, PMSC mutations in inlA were more common in food isolates (4 /11) and underrepresented in clinical 
isolates (1/11), despite the relatively low number of strains analyzed. Previous molecular epidemiology studies reported that a 
significant proportion of L. monocytogenes strains isolated from food products carry PMSC mutations in inlA, indicating that 
there is a significant subpopulation of L. monocytogenes strains in the food supply with a limited ability to cause human disease. 
Taken together, in addition to the significance of these findings for food safety and public health, these data contribute to our 
understanding of the ecology and evolution of L. monocytogenes. Future efforts to elucidate the selective advantages associated 
with  the  production  of  a  truncated  and  secreted  InlA protein  may  provide  a  better  understanding  of  the  function  of  L. 
monocytogenes internalins in different hosts and nonhost environments.	

      After the ingestion of contaminated food, L. monocytogenes has the ability to induce its own entry into mammalian cells 
such  as  macrophages,  epithelial  cells  and  endothelial  cells  of  the  gastrointestinal  tract  [10].  Internalin  A protein  (InlA) 
encoded by inlA has a key role in L. monocytogenes infection mechanism. InlA facilitates uptake of L. monocytogenes  by 
host cells expressing certain isoforms of E-cadherin, making the interaction between InlA and E-cadherin a critical first step 
for crossing the intestinal barrier during the initial stages of infection, in a process called internalization. A previous study 
characterized a set of paired isogenic mutants with and without an inlA premature stop codons (PMSC) using an intragastric 
guinea  pig  infection  model  demonstrate  that  inlA PMSC  mutations  appear  to  be  causally  associated  with  attenuated 
mammalian virulence [11]. L. monocytogenes isolates that carry a PMSC in inlA produce a truncated form of InlA that is 
secreted rather  than anchored to the bacterial  cell  wall  and demonstrate attenuated invasion of  Caco-2 human intestinal 
epithelial cells. [12, 13]. A number of studies suggests that lineages differ in their virulence characteristics; lineage II in 
particular including a considerable proportion of virulence-attenuated isolates (>30%) due to premature stop codons in inlA, 
while serotypes 4b and 1/2b isolates typically harbor a full length intact InlA [8, 9]. 	

      While there is substantial information on L. monocytogenes genetic diversity and epidemic potential, additional studies 
may reveal additional diversity and contribute to understanding on how L. monocytogenes subtypes differ in their virulence 
potential. This study aimed to characterize 22 L. monocytogenes strains, collected in Portugal, from human clinical cases 
(n=11) and different food products (n=11) in terms of invasion efficiency in Caco-2 cell line and detection of virulence-
attenuated mutations in inlA gene. 	

Prevalence of PMSC in L. monocytogenes strains	

Table 2. Characterization of L. monocytogenes strains with PMSC.	
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~104 Caco-2 cells/ml 	

1.  Serial dilutions in PBS	

2.  Spread in BHI agar plates	





















































Invasion efficiency in L. monocytogenes strains with PMSC mutations in inlA show	

reduced invasion efficiency in Caco-2 	

Figure 1. Caco-2 average invasion efficiency for selected L. monocytogenes strains, normalized 
to that of the control strain FSL F8-146 (full length inlA strain).	

Results 
      Table 2 shows the 3 different mutation types leading to PMSC detected in five L. monocytogenes strains recovered from food 
and clinical sources, belonging to different geno-serogroups. The remaining seventeen strains tested did not show PMSC in inlA.	

      The invasion efficiency in Caco-2 cell of the strains with PMSC were evaluated and compared with the positive control 




























































































































       For this study a set of 22 bacterial isolates from food and 
clinical  origin collected in Portugal  between were selected 
from  the  L.  monocytogenes  culture  collection  of  Escola 




      Table 1. Description of L. monocytogenes strains	

a Detection of serotype-specific marker genes was performed using 
a multiplex-PCR assay previously reported by Doumith et al. [13]. 
This  assay  differentiates  isolates  in  five  major  subtypes,  which 
each  represents  more  than  one  serotype,  including  (i)  geno-
seroproup IIa (which includes serotypes 1/2a and 3a);  (ii)  geno-
serogroup IIb (serotypes 1/2b, 3b, and 7); (iii) genoserogroup IIc 
(serotypes 1/2c and 3c ); and (iv) genoserogroup IVb (serotypes 
4b, 4d, and 4e).	





      For  invasion assays in the human intestinal epithelial 
caco-2 cell line a laboratory control strain presenting a full-
length  InlA (FSL F8-146)  and  a  strain  presenting  an  inlA 
PMSC (FSL F8-144) (previoully reported by Ferreira et al. 
[15])  were included as controls  in each invasion assay.  At 
least three independent invasion assays were performed for 
each  isolate.  Results  were  reported  as  percent  invasion 
efficiency  (i.e.,  bacterial  numbers  recovered/bacterial 
numbers inoculated), normalized to the values obtained for 




Intracellular L. monocytogenes 
cells were collected	





     L.  monocytogenes  strains  were  screened  for  the 
presence  of  PMSCs  in  inlA,  which  encodes  a  protein 
critical  for  invasion  of  Caco-2  cells.  Primer  sequences, 
PCR conditions, and sequencing strategies have previously 




1. Grow of 1 colony on BHI agar, at 37 ºC, overnight	

2. Centrifugation (10.000 g, 10 min) of 250 µL of bacterial cells	

3. Pellet resuspention  in 95 µL of 1xPCR buffer and 4 µL of 50 
mg/mL lysozyme solution	

4. Incubation at RT, 15 min	

5. Addiction of 1 µL of 20 mg/mL proteinase K, 58 ºC, 60 min	

6. Enzymes heat inactivation , 95 ºC, 10 min	























Four pairs of primers:	

•  inlA proF/inlA proR, 	

•  inlA F1/inlA S1R	

•  inlA F2/inlA S2R 	





KAPA HiFi DNA 
Polymerase	









Sequence analysis - Geneious 4.8.2 program; Mega 5.05. 	

b	  Seventeen mutations leading to PMSC in inlA have been detected between 1998 and 2010. In this study mutations have been 
classified according to categorization proposed by Van Stelten et al. [18]. 	  
      From the 22 L. monocytogenes strains characterized only five presented PMSC in inlA, namely one clinical isolate  (geno-
serogroup IIa,  lineage II),  and four food isolates (two genoserogroup IIb isolates,  lineage I,  and two geno-serogroup IIc, 
lineage II). These mutation types have been previously described in isolates from France, Portugal and USA [12, 15, 17]. 	

      Phenotypically, it was possible to relate the presence of PMSCs with invasion efficiencies below that of the positive 
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